Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US High Purity Solvents Market

ID: MRFR/CnM/16069-HCR
100 Pages
Chitranshi Jaiswal
Last Updated: April 06, 2026

US High Purity Solvents Market Research Report: By Type (Spectrophotometric Solvents, UHPLC and LC/MS Solvents, HPLC Solvents, GC Solvents), By Grade (ACS, Biosolv, Gcsolv, HPLC Grade, Omnisolv, Pestisolv, Purge & Trap, Spectrosolv, Tracegrade, USP, Ultratrace, Unisolv), By Category (Polar Solvent, Non-Polar Solvent), By Application (Liquid Crystals, Lithium Ion Batteries, Electroplating, Resins, Catalysts) and By End User (Pharmaceutical and Biopharmaceutical, Chemical Laboratories, Cosmetics, Food & Beverage, Agriculture, Paints & Coatings, Biotechnology, Electrical & Electronics) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US High Purity Solvents Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Million)
  49.     4.1.1 Spectrophotometric Solvents
  50.     4.1.2 UHPLC and LC/MS Solvents
  51.     4.1.3 HPLC Solvents
  52.     4.1.4 GC Solvents
  53.   4.2 Healthcare, BY Grade (USD Million)
  54.     4.2.1 ACS
  55.     4.2.2 biosolv
  56.     4.2.3 gcsolv
  57.     4.2.4 HPLC grade
  58.     4.2.5 omnisolv
  59.     4.2.6 pestisolv
  60.     4.2.7 purge & trap
  61.     4.2.8 spectrosolv
  62.     4.2.9 tracegrade
  63.     4.2.10 usp
  64.     4.2.11 ultratrace
  65.     4.2.12 unisolv
  66.   4.3 Healthcare, BY Category (USD Million)
  67.     4.3.1 Polar Solvent
  68.     4.3.2 Non-Polar Solvent
  69.   4.4 Healthcare, BY Application (USD Million)
  70.     4.4.1 Liquid Crystals
  71.     4.4.2 Lithium Ion Batteries
  72.     4.4.3 Electroplating
  73.     4.4.4 Resins
  74.     4.4.5 Catalysts
  75.   4.5 Healthcare, BY End User (USD Million)
  76.     4.5.1 Pharmaceutical and Biopharmaceutical
  77.     4.5.2 Chemical Laboratories
  78.     4.5.3 Cosmetics
  79.     4.5.4 Food & Beverage
  80.     4.5.5 Agriculture
  81.     4.5.6 Paints & Coatings
  82.     4.5.7 Biotechnology
  83.     4.5.8 Electrical & Electronics
  84. 5 SECTION V: COMPETITIVE ANALYSIS
  85.   5.1 Competitive Landscape
  86.     5.1.1 Overview
  87.     5.1.2 Competitive Analysis
  88.     5.1.3 Market share Analysis
  89.     5.1.4 Major Growth Strategy in the Healthcare
  90.     5.1.5 Competitive Benchmarking
  91.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  92.     5.1.7 Key developments and growth strategies
  93.       5.1.7.1 New Product Launch/Service Deployment
  94.       5.1.7.2 Merger & Acquisitions
  95.       5.1.7.3 Joint Ventures
  96.     5.1.8 Major Players Financial Matrix
  97.       5.1.8.1 Sales and Operating Income
  98.       5.1.8.2 Major Players R&D Expenditure. 2023
  99.   5.2 Company Profiles
  100.     5.2.1 Merck KGaA (DE)
  101.       5.2.1.1 Financial Overview
  102.       5.2.1.2 Products Offered
  103.       5.2.1.3 Key Developments
  104.       5.2.1.4 SWOT Analysis
  105.       5.2.1.5 Key Strategies
  106.     5.2.2 Honeywell International Inc. (US)
  107.       5.2.2.1 Financial Overview
  108.       5.2.2.2 Products Offered
  109.       5.2.2.3 Key Developments
  110.       5.2.2.4 SWOT Analysis
  111.       5.2.2.5 Key Strategies
  112.     5.2.3 BASF SE (DE)
  113.       5.2.3.1 Financial Overview
  114.       5.2.3.2 Products Offered
  115.       5.2.3.3 Key Developments
  116.       5.2.3.4 SWOT Analysis
  117.       5.2.3.5 Key Strategies
  118.     5.2.4 Thermo Fisher Scientific Inc. (US)
  119.       5.2.4.1 Financial Overview
  120.       5.2.4.2 Products Offered
  121.       5.2.4.3 Key Developments
  122.       5.2.4.4 SWOT Analysis
  123.       5.2.4.5 Key Strategies
  124.     5.2.5 Sigma-Aldrich (US)
  125.       5.2.5.1 Financial Overview
  126.       5.2.5.2 Products Offered
  127.       5.2.5.3 Key Developments
  128.       5.2.5.4 SWOT Analysis
  129.       5.2.5.5 Key Strategies
  130.     5.2.6 Fisher Scientific (US)
  131.       5.2.6.1 Financial Overview
  132.       5.2.6.2 Products Offered
  133.       5.2.6.3 Key Developments
  134.       5.2.6.4 SWOT Analysis
  135.       5.2.6.5 Key Strategies
  136.     5.2.7 VWR International (US)
  137.       5.2.7.1 Financial Overview
  138.       5.2.7.2 Products Offered
  139.       5.2.7.3 Key Developments
  140.       5.2.7.4 SWOT Analysis
  141.       5.2.7.5 Key Strategies
  142.     5.2.8 Avantor, Inc. (US)
  143.       5.2.8.1 Financial Overview
  144.       5.2.8.2 Products Offered
  145.       5.2.8.3 Key Developments
  146.       5.2.8.4 SWOT Analysis
  147.       5.2.8.5 Key Strategies
  148.   5.3 Appendix
  149.     5.3.1 References
  150.     5.3.2 Related Reports
  151. 6 LIST OF FIGURES
  152.   6.1 MARKET SYNOPSIS
  153.   6.2 US MARKET ANALYSIS BY TYPE
  154.   6.3 US MARKET ANALYSIS BY GRADE
  155.   6.4 US MARKET ANALYSIS BY CATEGORY
  156.   6.5 US MARKET ANALYSIS BY APPLICATION
  157.   6.6 US MARKET ANALYSIS BY END USER
  158.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  159.   6.8 RESEARCH PROCESS OF MRFR
  160.   6.9 DRO ANALYSIS OF HEALTHCARE
  161.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  162.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  163.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  164.   6.13 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  165.   6.14 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
  166.   6.15 HEALTHCARE, BY GRADE, 2024 (% SHARE)
  167.   6.16 HEALTHCARE, BY GRADE, 2024 TO 2035 (USD Million)
  168.   6.17 HEALTHCARE, BY CATEGORY, 2024 (% SHARE)
  169.   6.18 HEALTHCARE, BY CATEGORY, 2024 TO 2035 (USD Million)
  170.   6.19 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  171.   6.20 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  172.   6.21 HEALTHCARE, BY END USER, 2024 (% SHARE)
  173.   6.22 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
  174.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  175. 7 LIST OF TABLES
  176.   7.1 LIST OF ASSUMPTIONS
  177.     7.1.1
  178.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  179.     7.2.1 BY TYPE, 2025-2035 (USD Million)
  180.     7.2.2 BY GRADE, 2025-2035 (USD Million)
  181.     7.2.3 BY CATEGORY, 2025-2035 (USD Million)
  182.     7.2.4 BY APPLICATION, 2025-2035 (USD Million)
  183.     7.2.5 BY END USER, 2025-2035 (USD Million)
  184.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  185.     7.3.1
  186.   7.4 ACQUISITION/PARTNERSHIP
  187.     7.4.1

US Healthcare Market Segmentation

Healthcare By Type (USD Million, 2025-2035)

  • Spectrophotometric Solvents
  • UHPLC and LC/MS Solvents
  • HPLC Solvents
  • GC Solvents

Healthcare By Grade (USD Million, 2025-2035)

  • ACS
  • biosolv
  • gcsolv
  • HPLC grade
  • omnisolv
  • pestisolv
  • purge & trap
  • spectrosolv
  • tracegrade
  • usp
  • ultratrace
  • unisolv

Healthcare By Category (USD Million, 2025-2035)

  • Polar Solvent
  • Non-Polar Solvent

Healthcare By Application (USD Million, 2025-2035)

  • Liquid Crystals
  • Lithium Ion Batteries
  • Electroplating
  • Resins
  • Catalysts

Healthcare By End User (USD Million, 2025-2035)

  • Pharmaceutical and Biopharmaceutical
  • Chemical Laboratories
  • Cosmetics
  • Food & Beverage
  • Agriculture
  • Paints & Coatings
  • Biotechnology
  • Electrical & Electronics

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓